Citation Impact

Citing Papers

Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study
2008 Standout
Improving Selection Criteria for Early Cystectomy in High-Grade T1 Bladder Cancer: A Meta-Analysis of 15,215 Patients
2015
Sex Disparities in Cancer Mortality and Survival
2011
Colorectal cancer statistics, 2020
2020 Standout
Cancer statistics, 2022
2022 Standout
Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012
2013 Standout
Cancer statistics, 2023
2023 Standout
Antibody-drug conjugates—an emerging class of cancer treatment
2016
Cancer statistics, 2017
2017 Standout
Cancer statistics, 2020
2020 Standout
Cancer statistics, 2024
2024 Standout
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
2024 Standout
Cancer statistics, 2019
2019 Standout
Cancer statistics, 2018
2018 Standout
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
2021 Standout
Cancer Statistics, 2021
2021 Standout
Clinical evaluation of a method for detecting superficial transitional cell carcinoma of the bladder by light-induced fluorescence of protoporphyrin IX following topical application of 5-aminolevulinic acid: Preliminary results
1997
Primary liver cancer: Worldwide incidence and trends
2004 Standout
Photodynamic Therapy
1998 Standout
Global Cancer Statistics, 2002
2005 Standout
Ovarian cancer in younger vs older women: a population-based analysis
2006
Oral Contraceptives and Cancer
1996
Prognosis of Muscle-Invasive Bladder Cancer: Difference between Primary and Progressive Tumours and Implications for Therapy
2003
Guidelines on Bladder Cancer
2002
Head and neck cancer
2008 Standout
Lung Cancer: Epidemiology, Etiology, and Prevention
2011 Standout
Transurethral Resection and Surveillance of Bladder Cancer Supported by 5-Aminolevulinic Acid-Induced Fluorescence Endoscopy
1999
EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2013
2013 Standout
Image-guided cancer surgery using near-infrared fluorescence
2013 Standout
Predicting Recurrence and Progression in Individual Patients with Stage Ta T1 Bladder Cancer Using EORTC Risk Tables: A Combined Analysis of 2596 Patients from Seven EORTC Trials
2006 Standout
Bladder Cancer Incidence and Mortality: A Global Overview and Recent Trends
2016 Standout
Oral Contraceptives and Cancer
2001
Bladder cancer
2016 Standout
Borderline ovarian tumors in Sweden 1960–2005: Trends in incidence and age at diagnosis compared to ovarian cancer
2008
Trends in the Mortality (1950–1997) and Incidence (1975–1993) of Malignant Ovarian Neoplasm among Japanese Women: Analyses by Age, Time, and Birth Cohort
2001
Solid Cancer Incidence in Atomic Bomb Survivors: 1958–1998
2007 Standout
Recurrence and Progression of Disease in Non–Muscle-Invasive Bladder Cancer: From Epidemiology to Treatment Strategy
2009 Standout
Neglected Tropical Diseases in Sub-Saharan Africa: Review of Their Prevalence, Distribution, and Disease Burden
2009 Standout
Epidemiology and Risk Factors of Urothelial Bladder Cancer
2012 Standout
Sex differences in immune responses
2016 Standout
Global Patterns of Cancer Incidence and Mortality Rates and Trends
2010 Standout
Bladder cancer: Epidemiology, staging and grading, and diagnosis
2005 Standout
Nanoparticle-Based Medicines: A Review of FDA-Approved Materials and Clinical Trials to Date
2016 Standout
The present and future burden of urinary bladder cancer in the world
2009
Long-term trends in cancer mortality in the United States, 1930-1998
2003
Gender differences in stage-adjusted bladder cancer survival
2000
Therapeutic role of lymph node resection in endometrioid corpus cancer
2006
Estimates of cancer incidence and mortality in Europe in 2008
2010 Standout
EAU Guidelines on Non-Muscle-Invasive Urothelial Carcinoma of the Bladder
2008 Standout
EUROCARE-3: survival of cancer patients diagnosed 1990–94—results and commentary
2003
FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
2011 Standout
Familial Transitional Cell Carcinoma
1996
Transurethral Resection For Bladder Cancer Using 5-Aminolevulinic Acid Induced Fluorescence Endoscopy Versus White Light Endoscopy
2002
International Statistical Classification of Diseases and Related Health Problems
2014 Standout
Colorectal cancer statistics, 2017
2017 Standout
Cancer statistics, 2016
2016 Standout
Cancer statistics, 2015
2015 Standout
Imaging and Photodynamic Therapy: Mechanisms, Monitoring, and Optimization
2010 Standout
Hexyl Aminolevulinate Fluorescence Cystoscopy: A New Diagnostic Tool for Photodiagnosis of Superficial Bladder Cancer—A multicenter study
2003
Global cancer statistics, 2012
2015 Standout
The global burden of urinary bladder cancer
2008
PRIMARY SUPERFICIAL BLADDER CANCER RISK GROUPS ACCORDING TO PROGRESSION, MORTALITY AND RECURRENCE
2000
MULTIVARIATE ANALYSIS OF THE PROGNOSTIC FACTORS OF PRIMARY SUPERFICIAL BLADDER CANCER
2000
Detection of Early Bladder Cancer by 5-Aminolevulinic Acid Induced Porphyrin Fluorescence
1996

Works of N.P. Koper being referenced

Should random urothelial biopsies be taken from patients with primary superficial bladder cancer? A decision analysis
1994
Ovarian cancer incidence (1989–1991) and mortality (1954–1993) in the Netherlands
1996
Bladder cancer incidence and survival in the south-eastern part of the Netherlands, 1975–1989
1994
Serum CA 125 measurements to identify patients with endometrial cancer who require lymphadenectomy.
1998
333 Phase I dose-escalation trial with the DNA-alkylating anti-HER2 antibody-drug conjugate SYD985
2015
Rankless by CCL
2026